ARTICLE | Clinical News
APT070 genetically modified fragment of anti-CD35 antibody regulatory update
June 30, 2003 7:00 AM UTC
The FDA granted Orphan Drug designation to Adprotech's APT070 to prevent delayed graft function in solid organ transplantation. The product received Orphan Medicinal Product designation from the EU to...